[go: up one dir, main page]

JPS62419A - Water-soluble agent containing fat-soluble vitamin - Google Patents

Water-soluble agent containing fat-soluble vitamin

Info

Publication number
JPS62419A
JPS62419A JP60139935A JP13993585A JPS62419A JP S62419 A JPS62419 A JP S62419A JP 60139935 A JP60139935 A JP 60139935A JP 13993585 A JP13993585 A JP 13993585A JP S62419 A JPS62419 A JP S62419A
Authority
JP
Japan
Prior art keywords
water
soluble
fat
vitamin
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60139935A
Other languages
Japanese (ja)
Inventor
Yoichi Oota
陽一 太田
Norihiro Yoneda
米田 宣弘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP60139935A priority Critical patent/JPS62419A/en
Publication of JPS62419A publication Critical patent/JPS62419A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)

Abstract

PURPOSE:To obtain the titled water-soluble agent having extremely high stability and excellent safety and takable without feeling the taste and odor, by compounding a fat-soluble vitamin, a water-soluble polyhydric alcohol, a polyglycerol fatty acid ester, ethanol and water. CONSTITUTION:The objective water-soluble agent can be produced by compounding (A) preferably 0.5-30(wt)% fat-soluble vitamin (e.g. vitamin A, D, E, F, K, U, etc.), (B) preferably 2-95% water-soluble polyhydric alcohol having >=2 OH groups in the molecule (e.g. ethylene glycol), (C) preferably 0.2-5pts. (based on 1pt. of the component A) of a polyglycerol fatty acid eater (preferably having a glycerol polymerization degree of 6-15), (D) preferably 0.5-20% ethanol and (E) preferably 0.1-5pts. (based on 1pt. of the component B) of water.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、水溶性多価アルコール、ポリグリセリン脂肪
酸エステル、エタノール、および水を用いて製造した、
安定な脂溶性ビタミン含有水溶性剤に関するものである
[Detailed Description of the Invention] [Industrial Application Field] The present invention provides a method for producing a polyhydric alcohol, which is produced using a water-soluble polyhydric alcohol, a polyglycerol fatty acid ester, ethanol, and water.
The present invention relates to a stable water-soluble agent containing fat-soluble vitamins.

〔従来の技術〕[Conventional technology]

脂溶性ビタミンは、医薬、化粧品、食品分野で広く用い
られているが、これらのものは水にほとんど溶解しない
ために、水溶性剤にするには、非イオン性界面活性剤を
用いて油脂とともに乳化するか、アルコール水溶液に可
溶化する等の操作が必要である。そこで、本発明者らは
、非イオン性界面活性剤のうち、医薬、化粧品とともに
食品分野でも許可されているポリグリセリン脂肪酸エス
テルを用いて、脂溶性ビタミンの水溶性剤をつくること
を試みた。脂溶性ビタミンとポリグリセリン脂肪酸エス
テルの組み合わせで製剤化した例としては、特開昭58
−13508号公報が知られている。
Fat-soluble vitamins are widely used in the pharmaceutical, cosmetic, and food fields, but since these vitamins hardly dissolve in water, they must be mixed with fats and oils using a nonionic surfactant to make them water-soluble. Operations such as emulsification or solubilization in an aqueous alcohol solution are required. Therefore, the present inventors attempted to create a water-soluble agent for fat-soluble vitamins using polyglycerin fatty acid ester, which is a nonionic surfactant that is permitted in the food field as well as in pharmaceuticals and cosmetics. An example of a formulation made from a combination of fat-soluble vitamins and polyglycerin fatty acid esters is disclosed in JP-A-58
-13508 publication is known.

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

従来の脂溶性ビタミンの水溶性剤は注射剤、点眼剤、化
粧水、ドリンク剤等の水溶液系に配合した時に、系の安
定性に問題があった。これは、乳化系であれば、経時と
もに脂溶性成分が浮きでる、いわゆるクリーミング現象
が起こり、可溶化系であれば、系が壊れて脂溶性ビタミ
ンの析出が起こると言う現象である。そこで、本発明者
らは、こうした事情にかんがみ、脂溶性ビタミンの乳化
粒子系を0.5μ以下のマイクロエマルジョンにするこ
とで、水溶液系に安定に自由な割合で配合することので
きる脂溶性ビタミン含有水溶性剤をつくることが出来る
ことを見出した。これは、ストークス沈降速度式で、粒
子径を小さくすればする程、粒子の沈降速度が小さくな
ることに対応するもので、粒子径が小さくなれば、エマ
ルジョンが外観上、半透明〜透明になり、希釈しても白
濁が生じなく製品設計上好ましいものである。
Conventional water-soluble formulations of fat-soluble vitamins have problems with stability when incorporated into aqueous solutions such as injections, eye drops, lotions, and drinks. This is a phenomenon that occurs in emulsified systems, where fat-soluble components float out over time, a so-called creaming phenomenon, and in solubilized systems, the system breaks down and fat-soluble vitamins precipitate. In view of these circumstances, the present inventors developed a microemulsion of fat-soluble vitamin emulsion particles with a size of 0.5μ or less, thereby making it possible to stably incorporate fat-soluble vitamins into an aqueous solution system in any proportion. It has been discovered that it is possible to create a water-soluble agent containing This is based on the Stokes sedimentation velocity equation, which corresponds to the fact that the smaller the particle size, the lower the sedimentation speed of the particles.As the particle size becomes smaller, the emulsion becomes translucent to transparent in appearance. Even when diluted, cloudiness does not occur, which is preferable in terms of product design.

本発明者らはこの知見にもとづき、鋭意研究を重ねた結
果、脂溶性ビタミンと、分子内に2個以上の水酸基を有
する水溶性多価アルコール1種または2種以上とポリグ
リセリン脂肪酸エステルと、エタノールと水を配合し、
加圧ホモジナイザー処理すると脂溶性ビタミンがマイク
ロエマルジョンになった脂溶性ビタミン含有水溶性剤を
えることを見出し、本発明を完成するに至った。
Based on this knowledge, the present inventors conducted extensive research and found that fat-soluble vitamins, one or more water-soluble polyhydric alcohols having two or more hydroxyl groups in the molecule, and polyglycerin fatty acid esters, Combine ethanol and water,
It was discovered that a water-soluble agent containing fat-soluble vitamins in which fat-soluble vitamins are microemulsified can be obtained by treatment with a pressure homogenizer, and the present invention was completed.

このようにしてできたエマルジョンは非常に安定であり
、かつ、安全性に優れて、飲食した場合にも味、臭い等
全く問題のないものである。
The emulsion thus produced is very stable and has excellent safety, and there is no problem with taste or odor when it is eaten or eaten.

c問題を解決するための手段〕 すなわち、本発明は1種または2種以上の脂溶性ビタミ
ンと、分子内に2個以上の水酸基を有する水溶性多価ア
ルコールの1種または2種以上と、ポリグリセリン脂肪
酸エステル、エタノールおよび、水を配合してなる脂溶
性ビタミン含有水溶性剤である。
Means for Solving Problem C] That is, the present invention comprises one or more fat-soluble vitamins, one or more water-soluble polyhydric alcohols having two or more hydroxyl groups in the molecule, This is a water-soluble agent containing fat-soluble vitamins that contains polyglycerol fatty acid ester, ethanol, and water.

以下、本発明の構成について詳述する。Hereinafter, the configuration of the present invention will be explained in detail.

本発明における脂溶性ビタミンとしては、ビタミンA、
D、E、F、K及びUがあり、配合量は0.1〜50重
量%、好ましくは0.5〜30重量%がよい。
The fat-soluble vitamins in the present invention include vitamin A,
There are D, E, F, K and U, and the blending amount is 0.1 to 50% by weight, preferably 0.5 to 30% by weight.

また、本発明において用いられる分子内に2個以上の水
酸基を有する水溶性多価アルコールは、エチレングリコ
ール、プロピレングリコール、1.3−ブチレングリコ
ール、1,4−ブチレングリコール、ジプロピレングリ
コール、グリセリン及びジグリセリン、トリグリセリン
、テトラグリセリン、グルコース、マルトース、マルチ
トール、M糖、フラクトース、キシリトール、ソルビト
ール、マルトトリオース、スレイトール、エリスIJ 
)−ル、澱粉分解糖、澱粉分解糖還元アルコールなどが
あり、これらの配合量は2〜95重量%が好ましい。
In addition, the water-soluble polyhydric alcohols having two or more hydroxyl groups in the molecule used in the present invention include ethylene glycol, propylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, dipropylene glycol, glycerin and Diglycerin, triglycerin, tetraglycerin, glucose, maltose, maltitol, M sugar, fructose, xylitol, sorbitol, maltotriose, threitol, Eris IJ
), starch decomposition sugar, starch decomposition sugar reducing alcohol, etc., and the blending amount of these is preferably 2 to 95% by weight.

ポリグリセリン脂肪酸エステルはグリセリンの重合度及
び脂肪酸の種類、並びにそのエステル化度によりHLB
の高いものから低いものまで作ることが出来るが、ここ
では、グリセリンの重合度が6〜15までのものがよい
。重合度が5以下であるとHLBが低くなりすぎ、16
以上であると粘度が高くなりすぎるため扱いにくくなる
。また、脂肪酸は、ステアリン酸、ミリスチン酸、オレ
イン酸、ラウリン酸、バルミチン酸、ジイソステアリン
酸、リノール酸、リルン酸等天然物から合成のものまで
選択でき、エステル化度は、親水性の高いモノエステル
、ジエステルが望ましい。
Polyglycerin fatty acid ester has HLB depending on the degree of polymerization of glycerin, the type of fatty acid, and the degree of esterification.
Although it can be made from high to low glycerin, it is preferable to use glycerin with a polymerization degree of 6 to 15. If the degree of polymerization is 5 or less, HLB will be too low and 16
If it is more than that, the viscosity becomes too high and it becomes difficult to handle. In addition, fatty acids can be selected from natural products to synthetic ones, such as stearic acid, myristic acid, oleic acid, lauric acid, valmitic acid, diisostearic acid, linoleic acid, and lylunic acid. , diesters are preferred.

ポリグリセリン脂肪酸エステルの配合量は脂溶性ビタミ
ン量に対して 115〜5倍量が好ましい。
The amount of polyglycerin fatty acid ester blended is preferably 115 to 5 times the amount of fat-soluble vitamins.

また、エタノールの配合量は0.5〜20重量%が好ま
しく、0.5重量%未満では、配合する効果があまりな
く、20jlfffi%以上では、エマルジョンの安定
性が損なわれるためあまり好ましくない。次いで、これ
に水を添加し、加圧ホモジナイザー処理して、脂溶性ビ
タミンのマイクロエマルジョンを得るが、必要に応じ水
の一部を水相成分に添加して、加圧ホモジナイザー処理
した後に残りの水を攪拌しながら加えるとこもできる。
Further, the blending amount of ethanol is preferably 0.5 to 20% by weight, and if it is less than 0.5% by weight, the effect of blending is not so great, and if it is 20jlfffi% or more, the stability of the emulsion is impaired, so it is not so preferable. Next, water is added to this and subjected to pressure homogenization to obtain a microemulsion of fat-soluble vitamins. If necessary, a portion of the water is added to the aqueous phase component and the remaining water is extracted after pressure homogenization. You can also add water while stirring.

この際、初めの水の使用量は、水溶性多価アルコール量
の1/10〜5倍量が好ましい。本発明においては、上
記必須構成成分に加えて、さらに、レシチン、サポニン
、カゼイン、ゼラチン等天然物を系に加えることもでき
る。
At this time, the initial amount of water used is preferably 1/10 to 5 times the amount of water-soluble polyhydric alcohol. In the present invention, in addition to the above-mentioned essential components, natural products such as lecithin, saponin, casein, and gelatin can also be added to the system.

本発明は、広く、医薬、化粧品、食品に応用することが
できる。例えば、このままの形態あるいは希釈した形で
用いて、スキンローション、収れん化粧水、柔軟化粧水
、ヘアトニック、乳液、クリーム、ファウンデーション
などの化粧品、注射剤、点眼剤、尿素クリームなどの医
薬品、ジュース、ドリンク剤などの食品に配合すること
ができる。
The present invention can be widely applied to medicines, cosmetics, and foods. For example, it can be used as is or in diluted form to produce cosmetics such as skin lotions, astringent lotions, softening lotions, hair tonics, milky lotions, creams, and foundations, pharmaceuticals such as injections, eye drops, and urea creams, juices, It can be added to foods such as drinks.

本発明において乳化する際には、通常の攪拌乳化機でも
行なえるが、望ましくは、マントンガラリンホモジナイ
ザ−(米国マントンガラリン社Type 15M−8T
A)のような加圧乳化機を用いた高せん断力下で乳化を
した方が、より微細な粒子系のマイクロエマルジョンを
得ることができる。本発明の脂溶性ビタミン含有水溶性
剤の製造においては、必要により、等張化剤、緩衝剤、
溶解補助剤、矯味剤、防腐剤、安定化剤、比重調整剤等
をさらに適宜配合することができる。またミ本発明の脂
溶性ビタミン含有水溶性剤は、通常、調製時には平均0
.5μ以下の直径を持つ微細な乳化粒子から成り、加熱
滅菌に耐え、経時的な物理的安定性にも非常に優れてい
るものである。
Emulsification in the present invention can be carried out using a normal stirring emulsifying machine, but preferably a Manton Galarin homogenizer (Manton Galarin Co., Ltd. Type 15M-8T, USA)
A microemulsion with finer particles can be obtained by emulsifying under high shear force using a pressure emulsifier such as A). In the production of the fat-soluble vitamin-containing water-soluble agent of the present invention, an isotonizing agent, a buffering agent,
A solubilizing agent, a flavoring agent, a preservative, a stabilizer, a specific gravity adjuster, etc. can be further added as appropriate. In addition, the water-soluble agent containing fat-soluble vitamins of the present invention usually has an average of 0.
.. It consists of fine emulsified particles with a diameter of 5μ or less, can withstand heat sterilization, and has excellent physical stability over time.

(実施例) 次に実施例を示し、本発明をさらに詳しく説明する。な
お、本発明はこれにより限定されるものではない。配合
量は重9%である。
(Example) Next, an example will be shown to explain the present invention in more detail. Note that the present invention is not limited to this. The blending amount is 9% by weight.

実施例1 ■ マビソト                30■
 デカグリセリンモノオレイン酸 エステル 10 ■ 天然ビタミンE            10■ 
エチルアルコール          2■ クエン酸
               0.1■ 精製大豆レ
シチン          2■ 安息香酸ナトリウム
         0.2■ イオン交換水     
      残 余(lA法) ■に、■、■、■、■、■、■の一部(10ii%)を
順次添加して、室温にて混合溶解し、そこに■を攪拌し
ながら添加して、マントンガラリンホモジナイザ−50
0kg/cJの加圧条件で、8回処理する。さらに、■
の残部(36,7重量%)を攪拌しながら加えて、ビタ
ミンE含有水溶性剤を得た。
Example 1 ■ Mabisoto 30■
Decaglycerin monooleate 10 ■ Natural vitamin E 10 ■
Ethyl alcohol 2■ Citric acid 0.1■ Purified soybean lecithin 2■ Sodium benzoate 0.2■ Ion exchange water
Part (10ii%) of ■, ■, ■, ■, ■, ■ are sequentially added to the remainder (lA method) to ■, mixed and dissolved at room temperature, and ■ is added thereto with stirring. , Manton Galarin Homogenizer-50
The treatment is carried out 8 times under a pressurizing condition of 0 kg/cJ. Furthermore,■
The remainder (36.7% by weight) was added with stirring to obtain a vitamin E-containing water-soluble agent.

(安定性評価) 実施例1〜5で得られた本発明の脂溶性ビタミン含有水
溶性剤をイオン交換水内に5%の割合で配合し、室温に
1ケ月間放置した後、安定性を肉眼で評価した。クリー
ミングや分離が生じていないものを0として、クリーミ
ングや分離が生じたものを×として結果を表1に示した
(Stability evaluation) The fat-soluble vitamin-containing water-soluble agents of the present invention obtained in Examples 1 to 5 were mixed in ion-exchanged water at a ratio of 5%, and after being left at room temperature for one month, the stability was evaluated. Evaluation was made with the naked eye. The results are shown in Table 1, with 0 indicating no creaming or separation, and x indicating creaming or separation.

同様に比較例1も評価して表1に示した。Comparative Example 1 was similarly evaluated and shown in Table 1.

実施例2 ■ グリセリン           40■ ヘキサ
グリセリ ジイソステアリン酸エステル 15 ■ ビタミンA5 ■ エチルアルコール          10■ E
 D T A                O,0
5■ クエン酸                0.
10 安息香酸ナトリウム          0.2
■ イオン交換水           残 余(製法
) ■に、■、■、■、■、■、■を順次添加して室温にて
混合溶解し、そこに■を攪拌しながら添加して、マント
ンガラリンホモジナイザ−500kg/dの加圧条件で
、10回処理しビタミンA含有水溶性剤を得た。
Example 2 ■ Glycerin 40 ■ Hexaglyceride diisostearate 15 ■ Vitamin A5 ■ Ethyl alcohol 10 ■ E
D T A O, 0
5 ■ Citric acid 0.
10 Sodium benzoate 0.2
■ Ion-exchange water residue (manufacturing method) Add ■, ■, ■, ■, ■, ■ sequentially to ■, mix and dissolve at room temperature, add ■ to it while stirring, and add it using a Manton Galarin homogenizer The treatment was carried out 10 times under a pressure condition of -500 kg/d to obtain a vitamin A-containing water-soluble agent.

実施例3 ■ ソルビトール            35■ ペ
ンタデカグリセリン モノステアリン酸エステル  10 ■ ビタミンD               12■
 エチルアルコール         20■ ヘキサ
メタリン酸ナトリウム     0.02■ レシチン
              5■ クエン酸    
          0.1■ 安息香酸ナトリウム 
        0.2■ イオン交換水      
     残 余(製法) ■に、■、■、■、■1、■、■、■を順次添加して、
室温にて混合溶解し、そこに■を攪拌しながら添加して
、マントンガラリンホモジナイザー500kg / a
ntの加圧条件で、5回処理しビタミンD含有水溶性剤
を得た。
Example 3 ■ Sorbitol 35 ■ Pentadecaglycerin monostearate 10 ■ Vitamin D 12 ■
Ethyl alcohol 20 ■ Sodium hexametaphosphate 0.02 ■ Lecithin 5 ■ Citric acid
0.1■ Sodium benzoate
0.2 ■ Ion exchange water
Residue (manufacturing method) Add ■, ■, ■, ■1, ■, ■, ■ to the remaining ■ in order,
Mix and dissolve at room temperature, add ① to it while stirring, and use a Manton Galarin homogenizer 500 kg/a.
The treatment was carried out five times under a pressure condition of nt to obtain a vitamin D-containing water-soluble agent.

実施例4 ■ マビットン            15■ デカ
グリセリン モノオレイン酸エステル  7 ■ 天然ビタミンE80%         5■ シ
ュロースアセテートイソブチレート 3■ エチルアル
コール          0.5■ 安息香酸ナトリ
ウム         0.20 クエン酸     
         0.1■ イオン交換水     
      残 余(製法) ■に、■、■、■、■、■の一部(20重量%)を順次
添加して、室温にて混合溶解し、そこに■、■を混合し
たものを攪拌しながら添加して、マントンガラリンホモ
ジナイザ−500kg / crM 、 6回処理する
。さらに■の残部(49,8重量%)を攪拌しながら加
えて、ビタミンE含有水溶性剤を得た。
Example 4 ■ Mabitton 15 ■ Decaglycerin monooleate 7 ■ Natural vitamin E 80% 5 ■ Schroth acetate isobutyrate 3 ■ Ethyl alcohol 0.5 ■ Sodium benzoate 0.20 Citric acid
0.1 ■ Ion exchange water
Residue (manufacturing method) Part (20% by weight) of ■, ■, ■, ■, and ■ were sequentially added to the remaining ■, mixed and dissolved at room temperature, and the mixture of ■ and ■ was stirred. Add and process 6 times using a Manton Galarin homogenizer at 500 kg/crM. Further, the remaining part (49.8% by weight) of (1) was added with stirring to obtain a vitamin E-containing water-soluble agent.

実施例5 ■ プロピレングリコール       25■ デカ
グリセリン モノラウリン酸エステル  5 ■ ビタミンE8 ■ エチルアルコール          5■ クエ
ン酸                 0.1■ 安
息香酸ナトリウム         0.20 イオン
交換水           残 余(製法) ■に、■、■、■、■、■の−m(25ffiit%)
を順次添加して、室温にて混合熔解し、そこに■を攪拌
しながら添加して、マントンガラリンホモジナイザ−5
00kg / ctA 、 4回処理する。さらに■の
残部(29重量%)を攪拌しながら加えて、ビタミンE
含有水溶性剤を得た。
Example 5 ■ Propylene glycol 25 ■ Decaglycerin monolaurate 5 ■ Vitamin E8 ■ Ethyl alcohol 5 ■ Citric acid 0.1 ■ Sodium benzoate 0.20 Ion exchange water Remainder (manufacturing method) ■, ■, ■ ,■,■-m (25ffiit%)
were added sequentially, mixed and melted at room temperature, and then added with stirring, using a Manton Galarin homogenizer 5.
00 kg/ctA, treated 4 times. Furthermore, add the remainder of (29% by weight) of ■ while stirring, and add vitamin E.
A containing water-soluble agent was obtained.

比較例1 ■ ビタミンE5.0 ■ スクワラン             3.0■ 
ワセリン               2.0■ セ
スキオレイン酸ソルビタン     1.6■ ポリオ
キシエチレン         0.5オレイルエーテ
ル(20E、0.)   2゜4■ プロピレングリコ
ール        5.0■ 殺菌・防腐剤    
       通 量■ イオン交換水       
    残 量(製法) ■、■、■、■、■を75°Cに、■、■、■を73°
Cにそれぞれ加熱溶解し、油相を水相に攪拌しながら添
加して乳化し、その後30’Cまで冷却してビタミンE
含有水溶性剤を得た。
Comparative example 1 ■ Vitamin E 5.0 ■ Squalane 3.0 ■
Vaseline 2.0■ Sorbitan sesquioleate 1.6■ Polyoxyethylene 0.5 oleyl ether (20E, 0.) 2゜4■ Propylene glycol 5.0■ Disinfectant/preservative
Amount■ Ion exchange water
Remaining amount (manufacturing method) ■, ■, ■, ■, ■ at 75°C, ■, ■, ■ at 73°C
The oil phase is added to the aqueous phase while stirring to emulsify, and then cooled to 30'C to dissolve vitamin E.
A containing water-soluble agent was obtained.

Claims (3)

【特許請求の範囲】[Claims] (1)1種または2種以上の脂溶性ビタミンと、分子内
に2個以上の水酸基を有する水溶性多価アルコールの1
種または2種以上と、ポリグリセリン脂肪酸エステル、
エタノールおよび水を配合してなる脂溶性ビタミン含有
水溶性剤。
(1) One or more fat-soluble vitamins and a water-soluble polyhydric alcohol having two or more hydroxyl groups in the molecule.
species or two or more species, and polyglycerin fatty acid ester,
A water-soluble agent containing fat-soluble vitamins containing ethanol and water.
(2)ポリグリセリン脂肪酸エステルのグリセリン重合
度が6から15である特許請求の範囲第1項記載の脂溶
性ビタミン含有水溶性剤。
(2) The water-soluble agent containing fat-soluble vitamins according to claim 1, wherein the polyglycerin fatty acid ester has a degree of glycerin polymerization of 6 to 15.
(3)エタノールの配合量が0.5〜20重量%である
特許請求の範囲第1項記載の脂溶性ビタミン含有水溶性
剤。
(3) The water-soluble agent containing fat-soluble vitamins according to claim 1, wherein the amount of ethanol is 0.5 to 20% by weight.
JP60139935A 1985-06-26 1985-06-26 Water-soluble agent containing fat-soluble vitamin Pending JPS62419A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60139935A JPS62419A (en) 1985-06-26 1985-06-26 Water-soluble agent containing fat-soluble vitamin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60139935A JPS62419A (en) 1985-06-26 1985-06-26 Water-soluble agent containing fat-soluble vitamin

Publications (1)

Publication Number Publication Date
JPS62419A true JPS62419A (en) 1987-01-06

Family

ID=15257091

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60139935A Pending JPS62419A (en) 1985-06-26 1985-06-26 Water-soluble agent containing fat-soluble vitamin

Country Status (1)

Country Link
JP (1) JPS62419A (en)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62250941A (en) * 1986-04-23 1987-10-31 Taiyo Kagaku Co Ltd Preparation of emulsified or solubilized solution
JPS62263109A (en) * 1986-05-06 1987-11-16 Pola Chem Ind Inc Method for blending phospholipid stably
WO1994001074A1 (en) * 1992-07-13 1994-01-20 Shiseido Company, Ltd. Composition for dermatologic preparation
EP0623287A1 (en) * 1993-05-06 1994-11-09 Kraft Foods, Inc. Edible microemulsions of oil, water, alcohols and surfactant
US5686086A (en) * 1992-07-13 1997-11-11 Shiseido Co., Ltd. External skin treatment composition
US5798109A (en) * 1992-07-13 1998-08-25 Shiseido Company, Ltd. External skin treatment composition
EP0866117A1 (en) * 1997-03-17 1998-09-23 F. Hoffmann-La Roche Ag Microemulsion
US5962000A (en) * 1992-07-13 1999-10-05 Shiseido Company, Ltd. External skin treatment composition
WO2003063617A1 (en) * 2002-01-31 2003-08-07 Archer-Daniels-Midland Company Isotropic transparent compositions containing fat soluble vitamin
JP2006111539A (en) * 2004-10-12 2006-04-27 Taiyo Kagaku Co Ltd Polyglycerin fatty acid ester
JP2006346526A (en) * 2005-06-13 2006-12-28 Taiyo Kagaku Co Ltd Polyglycerin fatty acid ester and composition containing the same
JP2009197018A (en) * 1995-06-07 2009-09-03 Durect Corp Delivery system controlled by high viscosity liquid
US7629479B2 (en) 2004-10-12 2009-12-08 Taiyo Kagaku Co., Ltd. Polyglycerol fatty acid ester and composition containing same
JP2010178685A (en) * 2009-02-06 2010-08-19 Yakult Honsha Co Ltd Lipid soluble vitamin-containing beverage packed in hermetically sealed package, and method for producing the beverage
US7833543B2 (en) 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US9616055B2 (en) 2008-11-03 2017-04-11 Durect Corporation Oral pharmaceutical dosage forms
US9655861B2 (en) 2007-12-06 2017-05-23 Durect Corporation Oral pharmaceutical dosage forms
US9855333B2 (en) 2013-03-15 2018-01-02 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
US9918982B2 (en) 2002-12-13 2018-03-20 Durect Corporation Oral drug delivery system
US10471002B2 (en) 2002-06-25 2019-11-12 Durect Corporation Short duration depot formulations
US11083796B2 (en) 2005-07-26 2021-08-10 Durect Corporation Peroxide removal from drug delivery vehicle
US11400019B2 (en) 2020-01-13 2022-08-02 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
US12274794B2 (en) 2016-07-06 2025-04-15 Orient Pharma Co., Ltd. Oral dosage form with drug composition, barrier layer and drug layer
US12433877B2 (en) 2021-01-12 2025-10-07 Durect Corporation Sustained release drug delivery systems and related methods

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5637040A (en) * 1979-08-31 1981-04-10 Nippon Saafuakutanto Kogyo Kk Oil-in-polyhydric alcohol type emulsifying composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5637040A (en) * 1979-08-31 1981-04-10 Nippon Saafuakutanto Kogyo Kk Oil-in-polyhydric alcohol type emulsifying composition

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62250941A (en) * 1986-04-23 1987-10-31 Taiyo Kagaku Co Ltd Preparation of emulsified or solubilized solution
JPS62263109A (en) * 1986-05-06 1987-11-16 Pola Chem Ind Inc Method for blending phospholipid stably
WO1994001074A1 (en) * 1992-07-13 1994-01-20 Shiseido Company, Ltd. Composition for dermatologic preparation
US5484816A (en) * 1992-07-13 1996-01-16 Shiseido Company, Ltd. External skin treatment composition
US5686086A (en) * 1992-07-13 1997-11-11 Shiseido Co., Ltd. External skin treatment composition
US5798109A (en) * 1992-07-13 1998-08-25 Shiseido Company, Ltd. External skin treatment composition
US5962000A (en) * 1992-07-13 1999-10-05 Shiseido Company, Ltd. External skin treatment composition
US6024941A (en) * 1992-07-13 2000-02-15 Shiseido Company, Ltd. External skin treatment composition
EP0623287A1 (en) * 1993-05-06 1994-11-09 Kraft Foods, Inc. Edible microemulsions of oil, water, alcohols and surfactant
JP2009197018A (en) * 1995-06-07 2009-09-03 Durect Corp Delivery system controlled by high viscosity liquid
US7833543B2 (en) 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
AU729818B2 (en) * 1997-03-17 2001-02-08 Dsm Ip Assets B.V. Microemulsion
EP0866117A1 (en) * 1997-03-17 1998-09-23 F. Hoffmann-La Roche Ag Microemulsion
WO2003063617A1 (en) * 2002-01-31 2003-08-07 Archer-Daniels-Midland Company Isotropic transparent compositions containing fat soluble vitamin
US11179326B2 (en) 2002-06-25 2021-11-23 Durect Corporation Short duration depot formulations
US10471001B2 (en) 2002-06-25 2019-11-12 Durect Corporation Short duration depot formulations
US10471002B2 (en) 2002-06-25 2019-11-12 Durect Corporation Short duration depot formulations
US9918982B2 (en) 2002-12-13 2018-03-20 Durect Corporation Oral drug delivery system
JP2006111539A (en) * 2004-10-12 2006-04-27 Taiyo Kagaku Co Ltd Polyglycerin fatty acid ester
US7629479B2 (en) 2004-10-12 2009-12-08 Taiyo Kagaku Co., Ltd. Polyglycerol fatty acid ester and composition containing same
JP2006346526A (en) * 2005-06-13 2006-12-28 Taiyo Kagaku Co Ltd Polyglycerin fatty acid ester and composition containing the same
US11083796B2 (en) 2005-07-26 2021-08-10 Durect Corporation Peroxide removal from drug delivery vehicle
US10206883B2 (en) 2007-12-06 2019-02-19 Durect Corporation Oral pharamaceutical dosage forms
US9655861B2 (en) 2007-12-06 2017-05-23 Durect Corporation Oral pharmaceutical dosage forms
US9884056B2 (en) 2008-11-03 2018-02-06 Durect Corporation Oral pharmaceutical dosage forms
US10328068B2 (en) 2008-11-03 2019-06-25 Durect Corporation Oral pharmaceutical dosage forms
US9616055B2 (en) 2008-11-03 2017-04-11 Durect Corporation Oral pharmaceutical dosage forms
JP2010178685A (en) * 2009-02-06 2010-08-19 Yakult Honsha Co Ltd Lipid soluble vitamin-containing beverage packed in hermetically sealed package, and method for producing the beverage
US9907851B2 (en) 2013-03-15 2018-03-06 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
US10300142B2 (en) 2013-03-15 2019-05-28 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
US9855333B2 (en) 2013-03-15 2018-01-02 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
US12274794B2 (en) 2016-07-06 2025-04-15 Orient Pharma Co., Ltd. Oral dosage form with drug composition, barrier layer and drug layer
US11400019B2 (en) 2020-01-13 2022-08-02 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
US11771624B2 (en) 2020-01-13 2023-10-03 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
US12433877B2 (en) 2021-01-12 2025-10-07 Durect Corporation Sustained release drug delivery systems and related methods

Similar Documents

Publication Publication Date Title
JPS62419A (en) Water-soluble agent containing fat-soluble vitamin
EP1380278A1 (en) Cosmetic emulsion preparation and agent for external use
KR101116899B1 (en) Concentrated and diluted stable oil/water emulsions
JP2000212066A (en) Aqueous liquid preparation of fat-soluble material
JPS6361050B2 (en)
JPS60183032A (en) Emulsified composition
JP3489703B2 (en) Fine emulsion composition
MXPA05005720A (en) Emulsive water-soluble concentrates.
JP2011001289A (en) Method for producing emulsion and method for producing cosmetic
JPS63126544A (en) Microemulsion
JPS63126543A (en) Microemulsion
US3436459A (en) Fat soluble vitamin compositions
JPH01176442A (en) Oil-in-polyhydric alcohol type emulsified composition and oil-in-water type emulsified composition
JPH1171256A (en) Microemulsion composition
JPH09309813A (en) Preparation for external use for skin
JPH0364185B2 (en)
JPS58183938A (en) Emulsified composition
JPH09151112A (en) Microemulsion composition
JP4815575B2 (en) Method for producing composite emulsion
JPH0710338B2 (en) Oil-in-water emulsion composition and polyhydric alcohol-in-oil emulsion composition
JPH0435211B2 (en)
JP3978611B2 (en) Cosmetic composition
JPH0576337B2 (en)
JP2017061435A (en) Ceramide dispersion composition
JPH045490B2 (en)